Home » ETF » SBIO

SBIO - ALPS Medical Breakthroughs ETF

Stock Price: $48.53 USD 1.25 (2.64%)
Updated Apr 21, 2021 4:00 PM EDT - Market closed
Assets $236.90M
NAV $47.38
Expense Ratio 0.50%
PE Ratio n/a
Beta (5Y) 1.25
Dividend (ttm) n/a
Dividend Yield n/a
Ex-Dividend Date Dec 19, 2019
1-Year Return -
Trading Day April 21
Last Price $48.53
Previous Close $47.28
Change ($) 1.25
Change (%) 2.64%
Day's Open 47.09
Day's Range 46.76 - 48.56
Day's Volume 20,758
52-Week Range 36.00 - 64.04

Fund Description

The investment seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the S-Network® Medical Breakthroughs Index. The fund employs a passive management - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small- and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.

Asset Class
Portfolio-Multi Asset
Sector
Healthcare
Region
Global
Inception Date
Dec 31, 2014
Exchange
NYSEARCA
Ticker Symbol
SBIO
Index Tracked
Poliwogg Medical Breakthroughs Index

Top 10 Holdings

29.72% of assets
NameSymbolWeight
Fate TherapeuticsFATE4.27%
Vir BiotechnologyVIR4.18%
Arena PharmaceuticalsARNA2.94%
Agios PharmaceuticalsAGIO2.92%
Legend BiotechLEGN2.67%
Emergent BioSolutionsEBS2.63%
Apellis PharmaceuticalsAPLS2.63%
InsmedINSM2.52%
Springworks TherapeuticsSWTX2.50%
PTC TherapeuticsPTCT2.46%
View More Holdings

Dividends

Ex-DividendAmountPay Date
Dec 19, 2019$0.016Dec 27, 2019
Dec 20, 2018$0.784Dec 27, 2018
Dec 21, 2017$0.579Dec 28, 2017
Full Dividend History

News

Hide News
  • All
  • Videos
  • Conversation

Biotechnology sector-related exchange traded funds could stumble in the near-term as increased regulatory scrutiny weighs on drugmakers. Among the hardest hit areas of Tuesday, the ALPS Medical Breakthr...

Other tickers mentioned: IBB, XBI
4 weeks ago - ETF Trends

We have presented five ETFs that are easily crushing the Russell 2000 Index this year and are likely to continue their strong performance at least in the near term.

Other tickers mentioned: BFTR, CALF, CNBS, XSVM
2 months ago - Zacks Investment Research

Already off to a strong start in 2021, the ALPS Medical Breakthroughs ETF (SBIO) extended the good vibes by jumping 9% in the first full trading week of February. SBIO focuses on small- and mid-cap comp...

2 months ago - ETF Trends

Clinical trials are of the utmost importance to biotechnology investors, but not all exchange traded funds adequately address the phenomenon. The ALPS Medical Breakthroughs ETF (SBIO) takes a different ...

2 months ago - ETF Trends

Large cap biotechnology companies are flush with cash, and they're on the prowl for takeover targets, a scenario that could bode well for the ALPS Medical Breakthroughs ETF (SBIO). SBIO focuses on small...

3 months ago - ETF Trends

The biotech space had an impressive run on the bourses in 2020 as the coronavirus pandemic triggered a race to roll out vaccine and treatment.

Other tickers mentioned: ARKG, BBH, BNTX, BTEC, CNCR, FBT, IBB ...
3 months ago - Zacks Investment Research

After a lull in mergers and acquisitions activity, Big Pharma could begin to use its cash stores to buy out smaller targets, potentially fueling the momentum in biotechnology-related exchange traded fun...

Other tickers mentioned: IBBJ, XBI
3 months ago - ETF Trends

We have presented five ETFs that have easily crushed the Russell 2000 Index over the past three months.

Other tickers mentioned: CNBS, PSCE, PSCM, PSCT
4 months ago - Zacks Investment Research

This biotech ETF hits a new 52-week high. Are more gains in store for this ETF?

4 months ago - Zacks Investment Research

The Food and Drug Administration (FDA) appears likely to be active on the drug review front in the months, with COVID-19 in the way. Expect that activity could benefit exchange traded funds with exposur...

5 months ago - ETF Trends

Following presidential elections, biotechnology stocks and exchange traded funds often rally. If that historical precedent holds true to form, ETFs such as the ALPS Medical Breakthroughs ETF (SBIO), cou...

5 months ago - ETF Trends

Historically, biotechnology stocks and exchange traded funds thrive when elections are completed. And while the winner of the presidential race isn't crystal clear, the ALPS Medical Breakthroughs ETF (S...

5 months ago - ETF Trends

The month of October was downbeat for Wall Street due to election uncertainty, failed stimulus talks, subdued tech earnings and rising coronavirus cases on the global front.

Other tickers mentioned: CNBS, FNK, KBWR, REGL, SILJ, TPSC
5 months ago - Zacks Investment Research

Wall Street registered its first back-to-back monthly loss of this year, with Dow Jones closing out the worst month since March.

Other tickers mentioned: KRE, LIT, MSOS, REMX
5 months ago - Zacks Investment Research

With election year in the rearview mirror, 2021 could bring upside for biotechnology stocks and exchange traded funds if historical trends hold true to form. That would be a boon for the ALPS Medical Br...

5 months ago - ETF Trends

By ALPS Funds SBIO ON AN ALL-TIME HIGH, TRUMPING JULY’S PEAK While broader equity markets rallied last week, the ALPS Medical Breakthroughs ETF (SBIO) rallied over 10% to surpass its previous all-time h...

6 months ago - ETF Trends

The healthcare sector, biotechnology stocks included, are often politically sensitive and that sensitivity is elevated in presidential election years. That scenario is repeating this year, but investors...

6 months ago - ETF Trends

These funds could be the best ways for investors to tap the opportunity arising from the Bristol Myers-MyoKardia deal and will likely see smooth trading in the months to come.

Other tickers mentioned: ARKG, BBC, XBI, XPH
6 months ago - Zacks Investment Research

Biotechnology stocks and exchange traded funds recently retreated as some of the air came out of the coronavirus vaccine trade and amid election year jitters.

6 months ago - ETF Trends

By ALPS Funds Last week, the ALPS Medical Breakthroughs ETF (SBIO) posted gains of around 1% and outperformed broader equity markets as well as large-cap biotech indices. Valuations for SBIO’s small-to-...

7 months ago - ETF Trends

Biotech ETFs are popular and delivering for investors, but not all of these funds need the Covid-19 pandemic to soar.

Other tickers mentioned: ARKG, BTEC, CNCR, FBT, GERM, XBI
8 months ago - InvestorPlace

The technology sector is often viewed as the epicenter of disruption and innovation, but the healthcare sector isn’t far behind and the ALPS Medical Breakthroughs ETF (SBIO) is one of the preferred idea...

8 months ago - ETF Trends

The ALPS Medical Breakthroughs ETF (SBIO) is one of many biotechnology ETF garnering attention this year amid the race to defeat the coronavirus, but SBIO also offers investors allure that will extend b...

Other tickers mentioned: BBC, IBB
8 months ago - ETF Trends

The ALPS Medical Breakthroughs ETF (SBIO) is higher by almost 39% over the past 90 days. Importantly, that impressive move is underpinned by strong fundamentals throughout the broader healthcare sector.

9 months ago - ETF Trends

Already one of the ETFs at the center of the coronavirus investment thesis, the ALPS Medical Breakthroughs ETF (SBIO) could be poised for more upside as the U.S. grapples with a second wave of the respi...

9 months ago - ETF Trends

On Friday, FTSE Russell, one of the largest providers of benchmarks used by providers of index funds and ETFs, reshuffles its widely followed indexes, including the Russell 1000 and Russell 2000, among ...

9 months ago - ETF Trends

Biotechnology ETFs, including the ALPS Medical Breakthroughs ETF (SBIO), are on torrid paces in the second quarter. Yes, some of that bullishness is attributable to the industry’s efforts to vanquish th...

Other tickers mentioned: BBC, IBB
10 months ago - ETF Trends

In the world of biotechnology stocks and ETFs, investors are pumping up those names with exposure to coronavirus treatments and vaccines.

10 months ago - ETF Trends

This trio of uniquely focused exchange-traded funds could make you a lot of money.

Other tickers mentioned: CLOU, GDX, ICPT
11 months ago - The Motley Fool

The best small-cap ETFs for Q3 2020 are SILJ, SGDJ and SBIO.

Other tickers mentioned: SGDJ, SILJ
11 months ago - Investopedia

Follow Warren Buffett???s latest COVID-19-fighting tips with these ETF strategies.

Other tickers mentioned: ITB, PKB, SGDJ, XHB
11 months ago - Zacks Investment Research

These small-cap sector ETFs have put a great show in the past month and are likely to fare better in the post-lockdown period.

Other tickers mentioned: PKB, SGDJ, TAN
11 months ago - Zacks Investment Research

Don't ignore healthcare stocks because 2020 is an election year. Some of these funds are poised for big upside.

Other tickers mentioned: ARKG, IHF, KURE, PSCH, XHE, XLV
11 months ago - InvestorPlace

Pacer Financial has filed for Pacer BioThreat ETF to enjoy the first-mover advantage that provide investors an option to capitalize on the new opportunities triggered by coronavirus.

Other tickers mentioned: ARKG, PBE
11 months ago - Zacks Investment Research

Biotech and healthcare ETFs were pretty stable on Apr 23 despite the news that Gilead's Remdesivir failed to improve Covid-19 patients' condition.

Other tickers mentioned: BBH, CNCR, FBT, IBB, IDNA, IHE, IHF ...
11 months ago - Zacks Investment Research

The ALPS Medical Breakthroughs ETF (NYSEArca: SBIO) was a star performer among healthcare ETFs last year and with small- and mid-cap members of that sector looking poised to renew bullish trends this ye...

1 year ago - ETF Trends

The best Small-Cap ETFs for Q1 2020 are ACES, QCLN, and SBIO.

Other tickers mentioned: ACES, QCLN
1 year ago - Investopedia

The best Healthcare ETFs for Q1 2020 are BBC, SBIO, and KURE.

Other tickers mentioned: BBC, KURE
1 year ago - Investopedia

While Wall Street is surging this quarter, these sector ETFs offered even better performances to beat the market.

Other tickers mentioned: BBC, GNOM, IEZ, PXJ, SIL, SILJ, SMH ...
1 year ago - Zacks Investment Research

Can biotech ETFs repeat its success story of 2019 in the election year of 2020?

Other tickers mentioned: BBC, CNCR, HTEC, IBB, IDNA, PBE, XBI
1 year ago - Zacks Investment Research

Following the new deals in the healthcare space, a few biotech ETFs hit new highs.

Other tickers mentioned: BBC, CNCR, GNOM, IBB, XBI
1 year ago - Zacks Investment Research

Head: Why Biotech ETFs are Rising

YouTube video

Increasing M&A deals and cutting edge therapies are driving biotech ETFs higher.

Other tickers mentioned: ARKG, BBC, IBB, XBI
1 year ago - Zacks Investment Research

Biotech Boom Sends One ETF Flying to Close the Year

YouTube video

Dec.04 -- The ETF industry has something for everyone -- the ALPS Medical Breakthrough ETF (ticker: SBIO) tracks biotech and pharmaceutical names with one or more drugs in Phase two or three of FDA clin...

1 year ago - Bloomberg Markets and Finance

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to work in favor of the biotech market.

Other tickers mentioned: ARKG, BBH, BBP, BTEC, CNCR, FBT, IBB ...
1 year ago - Zacks Investment Research

Small caps started to show their momentum and are trying to catch up with the large cap peers. The Russell 2000 Index hit a new 52-week high.

Other tickers mentioned: ACES, GDXJ, SILJ, VBK
1 year ago - Zacks Investment Research

These ETFs deserve special thanks and attention going into the New Year.

Other tickers mentioned: ITB, SMH, TAN, XAR
1 year ago - Zacks Investment Research

Healthcare bounced back with an outperformance starting the fourth quarter.

Other tickers mentioned: BBC, CNCR, GNOM, IHF, IRWD, JNCE, OSMT ...
1 year ago - Zacks Investment Research

October has been kind to the U.S. stock market thanks to U.S.

Other tickers mentioned: CRAK, FTXL, SEA, WOOD
1 year ago - Zacks Investment Research

The healthcare sector, which has been the second-worst performer among the 11 major S&P 500 sectors this year, took the center stage this month with some outperformance compared to other sectors.

Other tickers mentioned: BBC, GNOM, IHF, XBI, XPH
1 year ago - Zacks Investment Research

The biotech sector got a boost over the past week from a flurry of positive news including trial results and deal activities.

Other tickers mentioned: BBC, BBP, BTEC, HEPA
1 year ago - Zacks Investment Research